Időskori makuladegeneráció: vizsgálatok itt: Japán

4 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  Where

  Amagasaki, Fukuoka, Fukushima, Meguro-ku, Nagoya, Sendai, Tennoji-Ku, Tokyo, Ube

  Életkor

  50 év and over

  People

  304 worldwide

  Run by

  Amgen

  See details and how to joinNCT07614776 · EU 2025-523500-72-00
• 2. fázisTaking people
  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  Where

  Amagasaki, Bunkyo Ku, Chiyoda-ku, Kobe

  Életkor

  50 év and over

  People

  272 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07441642 · EU 2025-523704-77-00
• 3. fázisTaking people
  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  Where

  Chiba, Fukuoka, Fukushima, Ginowan, Hyōgo, Mito, Miyazaki, Nagoya, Tokyo

  Életkor

  50 év and over

  People

  480 worldwide

  Run by

  4D Molecular Therapeutics

  See details and how to joinNCT07064759
• No phaseTaking people
  Progression Suppression and Retinal Regression in VEGF-resistant AMD

  Where

  Amagasaki, Nagoya, Ube

  Életkor

  18 év to 85 év

  People

  10

  Run by

  PharmaBio Corporation

  See details and how to joinNCT07005323